Grasp the latest information from Olin and understand the new trends in the industry.
On March 26, 2026, Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, Stock Code: 688319) and Westlake University officially signed a cooperation agreement. Following multiple on-site inspections and in-
Recently, the China National Intellectual Property Administration issued the Notice on Determining the Demonstration Creation Objects for the Construction of a National Intellectual Property Powerhouse (2025-2027). Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”) was successfully selected as a “National Intellectual Property Demonstration Enterprise Creation Object” by virtue of its systematic layout and outstanding achievements in the comprehensive management of in
He once led Sichuan Shuyang to become a leading enterprise in the blood product industry, led Zhongyuan Ruide from loss to profit in just three years to realize consecutive sales growth, and also revitalized Guiyang Qianfeng Bio-Products, then merged it into Taibang Biologic Group, and successfully entered the overseas capital market...In the more than 40 years of work, Fan Shaowen, a maker in Chengdu High-tech Zone, has repeatedly performed the “Midas Touch” to make many biological products ent
On March 17, 2020, the Cash-in of the First Batch of Project Policies and the Symposium of Biological Enterprises under “Measures to Strengthen Technological Breakthroughs and Material Support for COVID-19 Prevention and Control in Chengdu High-tech Zone” was held in Chengdu High-tech Zone to support 18 enterprises and 2 provincial medical institutions that deeply participated in epidemic prevention and control and made practical contributions.